Top

Published in:

14-10-2024 | Bariatric Surgery | Review

Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement

Authors: Ashraf Haddad, Michel Suter, Jan Willem Greve, Scott Shikora, Gerhard Prager, Barham Abu Dayyeh, Manoel Galvao, Karen Grothe, Miguel Herrera, Lilian Kow, Carel Le Roux, Mary O’Kane, Chetan Parmar, Luiz Gustavo Quadros, Almino Ramos, Josep Vidal, Ricardo V Cohen

Published in: Obesity Surgery | Issue 11/2024

Abstract

Obesity is a chronic disease that may require multiple interventions and escalation of therapy throughout the years. Until recently, no universal definition existed for recurrent weight gain and insufficient weight loss. Standardization of reporting is key so outcomes can be compared and data can be pooled. The recent IFSO consensus provided standard terminology and definitions that will likely resolve this in the future, and publishers will need to enforce for authors to use these definitions. This current IFSO position statement provides guidance for the management of recurrent weight gain after bariatric surgery.

Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric Surgery Survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg. 2021;12:1–12. https://doi.org/10.1007/s11695-020-05207-7.CrossRef

Ma P, Reddy S, Higa KD. Revisional bariatric/metabolic surgery: what dictates its indications? Curr Atheroscler Rep. 2016;18(7):42. https://doi.org/10.1007/s11883-016-0592-3.CrossRefPubMed

Salminen P, Kow L, Aminian A, Kaplan LM, Nimeri A, Prager G, Behrens E, White KP, Shikora S; IFSO Experts Panel. IFSO consensus on definitions and clinical practice guidelines for obesity management-an International Delphi study. Obes Surg. 2024 Jan;34(1):30–42. https://doi.org/10.1007/s11695-023-06913-8.

Hubbard VS, Hall WH. Gastrointestinal surgery for severe obesity. Obes Surg. 1991;1(3):257–65. https://doi.org/10.1381/096089291765560962.CrossRefPubMed

Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4(4):353–7. https://doi.org/10.1381/096089294765558331.CrossRefPubMed

Antoniou SA, Antoniou GA, Koch OO, Köhler G, Pointner R, Granderath FA. Laparoscopic versus open obesity surgery: a meta-analysis of pulmonary complications. Dig Surg. 2015;32(2):98–107. https://doi.org/10.1159/000371749.CrossRefPubMed

Ardila-Gatas J, Sharma G, Lloyd SJ, Khorgami Z, Tu C, Schauer PR, Brethauer SA, Aminian A. A nationwide safety analysis of discharge on the first postoperative day after bariatric surgery in selected patients. Obes Surg. 2019;29(1):15–22. https://doi.org/10.1007/s11695-018-3489-0.CrossRefPubMed

Abraham CR, Werter CR, Ata A, Hazimeh YM, Shah US, Bhakta A, Tafen M, Singh PT, Beyer TD, Stain SC. Predictors of hospital readmission after bariatric surgery. J Am Coll Surg. 2015;221(1):220–7. https://doi.org/10.1016/j.jamcollsurg.2015.02.018.CrossRefPubMed

Chen SY, Stem M, Schweitzer MA, Magnuson TH, Lidor AO. Assessment of postdischarge complications after bariatric surgery: a National Surgical Quality Improvement Program analysis. Surgery. 2015;158(3):777–86. https://doi.org/10.1016/j.surg.2015.04.028.CrossRefPubMed

10.

Aiolfi A, Tornese S, Bonitta G, Rausa E, Micheletto G, Bona D. Roux-en-Y gastric bypass: systematic review and Bayesian network meta-analysis comparing open, laparoscopic, and robotic approach. Surg Obes Relat Dis. 2019;15(6):985–94. https://doi.org/10.1016/j.soard.2019.03.006.CrossRefPubMed

11.

Sun S, Borisenko O, Spelman T, Ahmed AR. Patient characteristics, procedural and safety outcomes of bariatric surgery in England: a retrospective cohort study-2006-2012. Obes Surg. 2018;28(4):1098–108. https://doi.org/10.1007/s11695-017-2978-x.CrossRefPubMed

12.

Lazzati A, Audureau E, Hemery F, Schneck AS, Gugenheim J, Azoulay D, Iannelli A. Reduction in early mortality outcomes after bariatric surgery in France between 2007 and 2012: a nationwide study of 133,000 obese patients. Surgery. 2016;159(2):467–74. https://doi.org/10.1016/j.surg.2015.08.005.CrossRefPubMed

13.

Sundbom M, Näslund E, Vidarsson B, Thorell A, Ottoson J. Low overall mortality during 10 years of bariatric surgery: nationwide study on 63,469 procedures from the Scandinavian Obesity Registry. Surg Obes Relat Dis. 2020;16(1):65–70. https://doi.org/10.1016/j.soard.2019.10.012.CrossRefPubMed

14.

Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37https://doi.org/10.1001/jama.292.14.1724 Erratum in: JAMA. 2005 Apr 13;293(14):1728

15.

Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007 Oct;142(4):621–32; discussion 632–5. https://doi.org/10.1016/j.surg.2007.07.018.

16.

Franken RJ, Sluiter NR, Franken J, et al. Treatment options for weight regain or insufficient weight loss after sleeve gastrectomy: a systematic review and meta-analysis. Obes Surg. 2022;32(6):2035–46.PubMedCrossRef

17.

Van de Laar A. Bariatric Outcomes Longitudinal Database (BOLD) suggests excess weight loss and excess BMI loss to be inappropriate outcome measures. Demonstrating Better Alternatives Obes Surg. 2012;22(12):1843–7.PubMed

18.

Cooper TC, Simmons EB, Webb K, Burns JL, Kushner RF. Trends in weight regain following Roux-en-Y gastric bypass (RYGB) bariatric surgery. Obes Surg. 2015;25(8):1474–81.PubMedCrossRef

19.

King WC, Hinerman AS, Belle SH, Wahed AS, Courcoulas AP. Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes. JAMA. 2018;320(15):1560.PubMedPubMedCentralCrossRef

20.

Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.PubMedCrossRef

21.

Hanvold SE, Vinknes KJ, Løken EB, Hjartåker A, Klungsøyr O, Birkeland E, Risstad H, Gulseth HL, Refsum H, Aas AM. Does lifestyle intervention after gastric bypass surgery prevent weight regain? A Randomized clinical trial. Obes Surg. 2019;29(11):3419–31.PubMedCrossRef

22.

Kaouk L, Hsu AT, Tanuseputro P, Jessri M. Modifiable factors associated with weight regain after bariatric surgery: a scoping review. F1000Res. 2019 May 3;8:615.

23.

Singh RK, Kumar P, Mahalingam K. Molecular genetics of human obesity: a comprehensive review. C R Biol. 2017;340(2):87–108.PubMedCrossRef

24.

Shantavasinkul PC, Omotosho P, Corsino L, Portenier D, Torquati A. Predictors of weight regain in patients who underwent Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2016;12(9):1640–5.PubMedCrossRef

25.

de Hollanda A, Ruiz T, Jiménez A, Flores L, Lacy A. Vidal J Patterns of weight loss response following gastric bypass and sleeve gastrectomy. Obes Surg. 2015;25(7):1177–83.PubMedCrossRef

26.

Jiménez A, Pané A, Ibarzábal A, de Hollanda A, Tundidor D, Balibrea JM, Andreu A, Molero J, Cañizares S, Obach A, Moizé V, Flores L, Ortega E, Vidal J. Weight-loss thresholds after bariatric surgery and cardiovascular outcomes: more is better. Int J Obes (Lond). 2022;46(2):279–86.PubMedCrossRef

27.

Nedelcu M, Khwaja HA, Rogula TG. Weight regain after bariatric surgery-how should it be defined? Surg Obes Relat Dis. 2016;12(5):1129–2113.PubMedCrossRef

28.

Gerges WB, Omran H, Makram F. Conversion of laparoscopic sleeve gastrectomy after weight loss failure into laparoscopic one anastomosis gastric bypass: short-term safety and efficacy and effect of indications on outcome. Surg Endosc. 2022;36(2):1080–9.PubMedCrossRef

29.

Stanford FC. A practical guide to the use of weight loss medications after bariatric surgery for weight regain or inadequate weight loss. Surg Obes Relat Dis. 2019;15(1):128–32.PubMedCrossRef

30.

Corcelles R, Boules M, Froylich D, Hag A, Daigle CR, Aminian A, Brethauer SA, Burguera B, Schauer PR. Total weight loss as the outcome measure of choice after Roux-en-Y gastric bypass. Obes Surg. 2016;26(8):1794–8.PubMedCrossRef

31.

Grover BT, Morell MC, Kothari SN, Borgert AJ, Kallies KJ, Baker MT. Defining weight loss after bariatric surgery: a call for standardization. Obes Surg. 2019;29(11):3493–9.PubMedCrossRef

32.

El Ansari W, Elhag W. Weight regain and insufficient weight loss after bariatric surgery: definitions, prevalence, mechanisms, predictors, prevention and management strategies, and knowledge gaps-a scoping review. Obes Surg. 2021;31(4):1755–66.PubMedPubMedCentralCrossRef

33.

Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 update: micronutrients. Surg Obes Relat dis. 2017;13:727–41. https://doi.org/10.1016/j.soard.2016.12.018.CrossRefPubMed

34.

O'Kane M, Parretti HM, Pinkney J, Welbourn R, Hughes CA, Mok J, Walker N, Thomas D, Devin J, Coulman KD, Pinnock G, Batterham RL, Mahawar KK, Sharma M, Blakemore AI, McMillan I, Barth JH. British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev. 2020;21:e13087. https://doi.org/10.1111/obr.13087.

35.

Homan J, Betzel B, Aarts EO, et al. Vitamin and mineral deficiencies after biliopancreatic diversion and biliopancreatic diversion with duodenal switch—the rule rather than the exception. Obes Surg. 2015;25(9):1626–32.PubMedCrossRef

36.

Ahuja A, Tantia O, Goyal G, Chaudhuri T, Khanna S, Poddar A, Gupta S, Majumdar K. MGB-OAGB: effect of biliopancreatic limb length on nutritional deficiency, weight loss, and comorbidity resolution. Obes Surg. 2018;28:3439–45. https://doi.org/10.1007/s11695-018-3405-7.CrossRefPubMed

37.

Shoar S, Poliakin L, Rubenstein R, Saber AA. Single anastomosis duodeno-ileal switch (SADIS): a systematic review of efficacy and safety. Obes Surg. 2018;28(1):104–13.PubMedCrossRef

38.

Parrott JM, Craggs-Dino L, Faria SL, O’Kane M. The optimal nutritional programme for bariatric and metabolic surgery. Curr Obes Rep. 2020;9:326–38. https://doi.org/10.1007/s13679-020-00384-z.CrossRefPubMed

39.

Livingstone MBE, Redpath T, Naseer F, Boyd A, Martin M, Finlayson G, Miras AD, Bodnar Z, Kerrigan D, Pournaras DJ, le Roux CW, Spector AC, Price RK. Food intake following gastric bypass surgery: patients eat less but do not eat differently. J Nutr. 2022;152:2319–2332. https://doi.org/10.1093/jn/nxac164. Epub ahead of print. PMID: 35870806; PMCID: PMC9644182.

40.

Nielsen MS, Christensen BJ, Ritz C, Rasmussen S, Hansen TT, Bredie WLP, le Roux CW, Sjödin A, Schmidt JB. Roux-En-Y gastric bypass and sleeve gastrectomy does not affect food preferences when assessed by an ad libitum buffet meal. Obes Surg. 2017;27:2599–605. https://doi.org/10.1007/s11695-017-2678-6.CrossRefPubMed

41.

Nielsen MS, Rasmussen S, Christensen BJ, Ritz C, le Roux CW, Schmidt JB, Sjödin A. Bariatric surgery does not affect food preferences, but individual changes in food preferences may predict weight loss. Obesity. 2018;12:1879–87. https://doi.org/10.1002/oby.22272.CrossRef

42.

Sarwer DB, Dilks RJ, West-Smith L. Dietary intake and eating behavior after bariatric surgery: threats to weight loss maintenance and strategies for success. Surg Obes Relat Dis. 2011;7:644–51. https://doi.org/10.1016/j.soard.2011.06.016.CrossRefPubMed

43.

Kofman MD, Lent MR, Swencionis C. Maladaptive eating patterns, quality of life, and weight outcomes following gastric bypass: results of an Internet survey. Obesity. 2010;18:1938–43. https://doi.org/10.1038/oby.2010.27.

44.

Colles SL, Dixon JB, O'Brien PE. Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. Obesity.. 2008;16:615–22. https://doi.org/10.1038/oby.2007.101. Erratum in: Obesity (Silver Spring). 2011 Nov;19(11):2287.

45.

Mitchell JE, Christian NJ, Flum DR, Pomp A, Pories WJ, Wolfe BM, Courcoulas AP, Belle SH. Postoperative behavioral variables and weight change 3 years after bariatric surgery. JAMA Surg. 2016;151:752–7. https://doi.org/10.1001/jamasurg.2016.0395.CrossRefPubMedPubMedCentral

46.

Smith KE, Engel SG, Steffen KJ, Garcia L, Grothe K, Koball A, Mitchell JE. Problematic alcohol use and associated characteristics following bariatric surgery. Obes Surg. 2018;28(5):1248–54. https://doi.org/10.1007/s11695-017-3008-8.CrossRefPubMedPubMedCentral

47.

Wong E, Fleishman A, Brem A, Jones DB, Wee CC. High-risk alcohol use and disordered eating behavior before and 1 year after sleeve gastrectomy. Obes Surg. 2022;32(3):593–598. https://doi.org/10.1007/s11695-021-05847-3.

48.

Papamargaritis D, le Roux CW. Do gut hormones contribute to weight loss and glycaemic outcomes after bariatric surgery? Nutrients. 2021;13:762. https://doi.org/10.3390/nu13030762.CrossRefPubMedPubMedCentral

49.

Lee PC, Dixon JB, Sim PY, Lim CH. Treatment options for poor responders to bariatric surgery. Curr Obes Rep. 2020;9(3):364–72. https://doi.org/10.1007/s13679-020-00381-2.CrossRefPubMed

50.

Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis. 2020;16(2):175–247. https://doi.org/10.1016/j.soard.2019.10.025.CrossRefPubMed

51.

Sarwer DB, Heinberg LJ. A review of the psychosocial aspects of clinically severe obesity and bariatric surgery. Am Psychol. 2020;75(2):252–64. https://doi.org/10.1037/amp0000550.CrossRefPubMedPubMedCentral

52.

Sogg S, Lauretti J, West-Smith L. Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients. Surg Obes Rel Dis. 2016;12(4):731–49. https://doi.org/10.1016/j.soard.2016.02.008.CrossRef

53.

Dawes AJ, Maggard-Gibbons M, Maher AR, et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA. 2016;315(2):150–63. https://doi.org/10.1001/jama.2015.18118.CrossRefPubMed

54.

de Zwaan M, Enderle J, Wagner S, Mühlhans B, Ditzen B, Gefeller O. Anxiety and depression in bariatric surgery patients: a prospective, follow-up study using structured clinical interviews. J Affect Disord. 2011;133(1):61–8. https://doi.org/10.1016/j.jad.2011.03.025.CrossRefPubMed

55.

Bhatti JA, Nathens AB, Thiruchelvam D, Grantcharov T, Goldstein BI, Redelmeier DA. Self-harm emergencies after bariatric surgery: a population-based cohort study [published online October 7, 2015] . JAMA Surg. https://doi.org/10.1001/jamasurg.2015.3414.

56.

Gordon KH, King WC, White GE, Belle SH, Courcoulas AP, Ebel FE, Engel SG, Flum DR, Hinojosa MW, Pomp A, Pories WJ, Spaniolas D, Wolfe BM, Yanovski SZ, Mitchell JE. A longitudinal examination of suicide-related thoughts and behaviors among bariatric surgery patients. Surg Obes Rel Dis 2019;15(2):269–278. ISSN 1550–7289 https://doi.org/10.1016/j.soard.2018.12.001.

57.

Parikh M, Johnson JM, Ballem N. ASMBS position statement on alcohol use before and after bariatric surgery. Surg Obes Rel Dis. 2016;12(2):225–30. https://doi.org/10.1016/j.soard.2015.10.085.CrossRef

58.

King WC, Chen JY, Courcoulas AP, Dakin GF, Engel SG, Flum DR, Hinojosa MW, Kalarchian MA, Mattar SG, Mitchell JE, Pomp A, Pories WJ, Steffen KJ, White GE, Wolfe BM, Yanovski SZ. Alcohol and other substance use after bariatric surgery: prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis. 2017 Aug;13(8):1392–1402. https://doi.org/10.1016/j.soard.2017.03.021.

59.

Strømmen M, Bakken IJ, Klöckner C, Sandvik J, Kulseng B, Holen A. Diagnoses related to abuse of alcohol and addictive substances after gastric bypass and sleeve gastrectomy: a nation-wide registry study from Norway. Surg Obes Rel Dis. 2020;16(4):464–70. https://doi.org/10.1016/j.soard.2019.12.011.CrossRef

60.

Svensson P-A, Anveden Å, Romeo S, Peltonen M, Ahlin S, Burza MA, Carlsson B, Jacobson P, Lindroos A-K, Lönroth H, Maglio C, Näslund I, Sjöholm K, Wedel H, Söderpalm B, Sjöström L, Carlsson LMS. Alcohol consumption and alcohol problems after bariatric surgery in the Swedish obese subjects study. Obesity. 2013;21:2444–51. https://doi.org/10.1002/oby.20397.CrossRefPubMed

61.

King WC, Chen JY, Belle SH, Courcoulas AP, Dakin GF, Flum DR, Hinojosa MW, Kalarchian MA, Mitchell JE, Pories WJ, Spaniolas K, Wolfe BM, Yanovski SZ, Engel SG, Steffen KJ. Use of prescribed opioids before and after bariatric surgery: prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis. 2017 Aug;13(8):1337–1346. https://doi.org/10.1016/j.soard.2017.04.003.

62.

Jung F, Lee Y, Manzoor S, et al. Effects of perioperative cannabis use on bariatric surgical outcomes: a systematic review. OBES SURG. 2021;31:299–306. https://doi.org/10.1007/s11695-020-04962-.CrossRefPubMed

63.

Diggins A, Heinberg L. Marijuana and bariatric surgery. Curr Psychiatry Rep. 2021;23:10. https://doi.org/10.1007/s11920-020-01218-4.CrossRefPubMed

64.

Carter J, Chang J, Birriel TJ, Moustarah F, Sogg S, Goodpaster K, Benson-Davies S, Chapmon K, Eisenberg D. ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery. Surg Obes Relat Dis. 2021;17(12):1956–76. https://doi.org/10.1016/j.soard.2021.08.024.CrossRefPubMed

65.

Griauzde DH, Ibrahim AM, Fisher N, Stricklen A, Ross R, Ghaferi AA. Understanding the psychosocial impact of weight loss following bariatric surgery: a qualitative study. BMC Obes. 2018;3(5):38. https://doi.org/10.1186/s40608-018-0215-3.CrossRef

66.

Kalarchian MA, Marcus MD. Psychosocial interventions pre and post bariatric surgery. Eur Eating Disorders Rev J Eating Disorders Assoc. 2015;23(6):457–62.CrossRef

67.

Bruze G, Holmin TE, Peltonen M, et al. Associations of bariatric surgery with changes in interpersonal relationship status: results from 2 Swedish cohort studies. JAMA Surg. 2018;153(7):654–61. https://doi.org/10.1001/jamasurg.2018.0215.CrossRefPubMedPubMedCentral

68.

Smith KE, Orcutt M, Steffen KJ, Crosby RD, Cao L, Garcia L, Mitchell JE(2019) Loss of control eating and binge eating in the 7 years following bariatric surgery. Obes Surg 1–8.

69.

Stewart F, Avenell A. Behavioural interventions for severe obesity before and/or after bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2016Jun;26(6):1203–14. https://doi.org/10.1007/s11695-015-1873-6.CrossRefPubMed

70.

Rudolph A, Hilbert A. Post-operative behavioural management in bariatric surgery: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2013 Apr;14(4):292–302. https://doi.org/10.1111/obr.12013. Erratum in: Obes Rev. 2014 Jan;15(1):74–5.

71.

Kaly P, Orellana S, Torrella T, Takagishi C, Saff-Koche L, Murr MM. Unrealistic weight loss expectations in candidates for bariatric surgery. Surg Obes Rel Dis 2008;4(1):6–10.ISSN 1550–7289, https://doi.org/10.1016/j.soard.2007.10.012.

72.

de Vries CEE, Terwee CB, Al Nawas et al. Outcomes of the first global multidisciplinary consensus meeting including persons living with obesity to standardize patient-reported outcome measurement in obesity treatment research. Obes Rev. 2022 Aug;23(8):e13452. https://doi.org/10.1111/obr.13452.

73.

Moroshko I, Brennan L, Warren N, Brown W, O’Brien P. Patients’ perspectives on laparoscopic adjustable gastric banding (LAGB) aftercare attendance: qualitative assessment. Obes Surg. 2014;24:266–75. https://doi.org/10.1007/s11695-013-1086-9.CrossRefPubMed

74.

Pinto-Bastos A, Conceição EM, Machado PPP. Reoperative bariatric surgery: a systematic review of the reasons for surgery, medical and weight loss outcomes, relevant behavioral factors. Obes Surg. 2017;27:2707-2715. https://doi.org/10.1007/s11695-017-2855-7. Erratum in: Obes Surg. 2017 Nov;27(11):3069-3072

75.

Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. OBES SURG. 2023;33:3–14. https://doi.org/10.1007/s11695-022-06332-1.CrossRefPubMed

76.

National Institute for Health and Care Excellence. NICE CG189 Obesity: identification, assessment and management of overweight and obesity in children, young people and adults. London: National Institute for Health and Care Excellence; 2014 [Internet] Available from: http://www.nice.org.uk/guidance/cg189

77.

Mahawar KK, Himpens JM, Shikora SA, et al. The first consensus statement on revisional bariatric surgery using a modified Delphi approach. Surg Endosc. 2020;34:1648–57. https://doi.org/10.1007/s00464-019-06937-1.CrossRefPubMed

78.

Heneghan HM, Yimcharoen P, Brethauer SA, Kroh M, Chand B. Influence of pouch and stoma size on weight loss after gastric bypass. Surg Obes Relat Dis. 2012;8(4):408–15.PubMedCrossRef

79.

Yimcharoen P, Heneghan HM, Singh M, Brethauer S, Schauer P, Rogula T, et al. Endoscopic findings and outcomes of revisional procedures for patients with weight recidivism after gastric bypass. Surg Endosc. 2011;25(10):3345–52.PubMedCrossRef

80.

Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, Buchwald H, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783–94.PubMedCrossRef

81.

Thompson CC, Slattery J, Bundga ME, Lautz DB. Peroral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-en-Y gastric bypass: a possible new option for patients with weight regain. Surg Endosc. 2006;20(11):1744–8.PubMedCrossRef

82.

Jirapinyo P, Kumar N, AlSamman MA, Thompson CC. Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest Endosc. 2020;91(5):1067–73.PubMedCrossRef

83.

Brunaldi VO, Jirapinyo P, de Moura DTH, Okazaki O, Bernardo WM, Galvão Neto M, Campos JM, Santo MA, de Moura EGH. Endoscopic treatment of weight regain following Roux-en-Y gastric bypass: a systematic review and meta-analysis. Obes Surg. 2018;28(1):266–76. https://doi.org/10.1007/s11695-017-2986-x.CrossRefPubMed

84.

Jaruvongvanich V, Vantanasiri K, Laoveeravat P, Matar RH, Vargas EJ, Maselli DB, Alkhatry M, Fayad L, Kumbhari V, Fittipaldi-Fernandez RJ, Hollenbach M, Watson RR, Gustavo de Quadros L, Galvao Neto M, Aepli P, Staudenmann D, Brunaldi VO, Storm AC, Martin JA, Gomez V, Abu Dayyeh BK. Endoscopic full-thickness suturing plus argon plasma mucosal coagulation versus argon plasma mucosal coagulation alone for weight regain after gastric bypass: a systematic review and meta-analysis. Gastrointest Endosc. 2020 Dec;92(6):1164–1175.e6. https://doi.org/10.1016/j.gie.2020.07.013.

85.

Aly A. Argon plasma coagulation and gastric bypass - a novel solution to stomal dilation. Obes Surg. 2009;19(6):788–90.PubMedCrossRef

86.

Baretta GA, Alhinho HC, Matias JE, Marchesini JB, de Lima JH, Empinotti C, et al. Argon plasma coagulation of gastrojejunal anastomosis for weight regain after gastric bypass. Obes Surg. 2015;25(1):72–9.PubMedCrossRef

87.

de Quadros LG, Neto MG, Marchesini JC, Teixeira A, Grecco E, Junior RLK, et al. Endoscopic argon plasma coagulation vs. multidisciplinary evaluation in the management of weight regain after gastric bypass surgery: a randomized controlled trial with SHAM group. Obes Surg. 2020;30(5):1904–16.

88.

Brunaldi VO, Ayala Farias GF, Tavares de Rezende D, Cairo-Nunes G, Riccioppo D, Hourneaux de Moura DT, et al. Argon plasma coagulation alone versus endoscopic suturing plus argon plasma coagulation to treat weight regain after Roux-en-Y gastric bypass: a prospective randomized trial (with videos). Gastrointest Endosc. 2020; 92(1):97–107.e5. https://doi.org/10.1016/j.gie.2020.03.3757.

89.

Vargas EJ, Bazerbachi F, Rizk M, Rustagi T, Acosta A, Wilson EB, Wilson T, Neto MG, Zundel N, Mundi MS, Collazo-Clavell ML, Meera S, Abu-Lebdeh HS, Lorentz PA, Grothe KB, Clark MM, Kellogg TA, McKenzie TJ, Kendrick ML, Topazian MD, Gostout CJ, Abu Dayyeh BK. Transoral outlet reduction with full thickness endoscopic suturing for weight regain after gastric bypass: a large multicenter international experience and meta-analysis. Surg Endosc. 2018;32(1):252–9.PubMedCrossRef

90.

Dolan RD, Jirapinyo P, Thompson CC. Endoscopic versus surgical gastrojejunal revision for weight regain in Roux-en-Y gastric bypass patients: 5-year safety and efficacy comparison. Gastrointest Endosc. 2021;94(5):945–50.PubMedPubMedCentralCrossRef

91.

Elnahas AI, Jackson TD, Hong D. Management of failed laparoscopic Roux-en-Y gastric bypass. Bariatr Surg Pract Patient Care. 2014;9(1):36–40.PubMedPubMedCentralCrossRef

92.

Ghiassi S, Higa K, Chang S, Ma P, Lloyd A, Boone K, DeMaria EJ. Conversion of standard Roux-en-Y gastric bypass to distal bypass for weight loss failure and metabolic syndrome: 3-year follow-up and evolution of technique to reduce nutritional complications. Surg Obes Relat Dis. 2018;14(5):554–61.PubMedCrossRef

93.

Tran DD, Nwokeabia ID, Purnell S, Zafar SN, Ortega G, Hughes K, Fullum TM. Revision of Roux-En-Y gastric bypass for weight regain: a systematic review of techniques and outcomes. Obes Surg. 2016;26(7):1627–34.PubMedCrossRef

94.

Boerboom A, Aarts E, Lange V, Plamper A, Rheinwalt K, Linke K, Peterli R, Berends F, Hazebroek E. Banding the pouch with a non-adjustable ring as revisional procedure in patients with insufficient results after Roux-en-Y gastric bypass: short-term outcomes of a multicenter cohort study. Obes Surg. 2020;30(3):797–803. https://doi.org/10.1007/s11695-019-04361-x.CrossRefPubMed

95.

Jacobs K, Vleeschouwers W, Debergh I, Haesen D, Dillemans B. Laparoscopic adjustable gastric banding with the Adhesix® Bioring® for weight regain or insufficient weight loss after a Roux-en-Y gastric bypass: midterm data from the Pronto Registry. Obes Surg. 2021;31(10):4295–304. https://doi.org/10.1007/s11695-021-05537-0.CrossRefPubMed

96.

Sohail AH, Howell RS, Brathwaite BM, Silverstein J, Amodu L, Cherasard P, Petrone P, Goparaju A, Levine J, Kella V, Brathwaite CEM. Gastric banding with previous Roux-en-Y gastric bypass (band over pouch): not worth the weight. JSLS. 2022 Apr-Jun;26(2):e2022.00010. https://doi.org/10.4293/JSLS.2022.00010.

97.

Brolin RE, Kenler HA, Gorman JH, Cody RP. Long-limb gastric bypass in the superobese A prospective randomized study. Ann Surg. 1992;215(4):387–95.PubMedPubMedCentralCrossRef

98.

Wang A, Poliakin L, Sundaresan N, Vijayanagar V, Abdurakhmanov A, Thompson KJ, McKillop IH, Barbat S, Bauman R, Gersin KS, Kuwada TS, Nimeri A. The role of total alimentary limb length in Roux-en-Y gastric bypass: a systematic review. Surg Obes Relat Dis. 2022;18(4):555–63.PubMedCrossRef

99.

Shah K, Nergard BJ, Fagerland MW, Gislason H. Failed Roux-en-Y gastric bypass-long-term results of distalization with total alimentary limb length of 250 or 300 cm. Obes Surg, 2022.

100.

Pokala B, Giannopoulos S, Athanasiadis DI, Motamedi SMK, Stefanidis D. Distal gastric bypass revision for weight recurrence or nonresponse to primary procedure: initial experience and outcomes in an academic practice. Surg Endosc, 2022.

101.

Kermansaravi M, Davarpanah Jazi AH, Shahabi Shahmiri S, Eghbali F, Valizadeh R, Rezvani M. Revision procedures after initial Roux-en-Y gastric bypass, treatment of weight regain: a systematic review and meta-analysis. Updates Surg. 2021 Jan 11. https://doi.org/10.1007/s13304-020-00961-w.

102.

Robert M, Poghosyan T, Maucort-Boulch D, Filippello A, Caiazzo R, Sterkers A, Khamphommala L, Reche F, Malherbe V, Torcivia A, Saber T, Delaunay D, Langlois-Jacques C, Suffisseau A, Bin S, Disse E, Pattou F. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA): a prospective, open-label, non-inferiority, randomised extension study. Lancet Diabetes Endocrinol. 2024;12(4):267–76. https://doi.org/10.1016/S2213-8587(24)00035-4.CrossRefPubMed

103.

Fehervari M, Banh S, Varma P, et al. Weight loss specific to indication, remission of diabetes, and short-term complications after sleeve gastrectomy conversion to Roux-en-Y gastric bypass: a systematic review and meta-analysis. Surg Obes Relat Dis. 2022 Nov 11:S1550-7289(22)00757-2https://doi.org/10.1016/j.soard.2022.11.004

104.

Diaz del Gobbo G, Mahmoud N, Barajas-Gamboa JS, et al. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass to enhance weight loss: single enterprise mid-term outcomes and literature review. Bar Surg Pract Pat Care 2022; 17(4): 197–205.

105.

Felsenreich DM, Steinlechner K, Langer FB, et al. Outcome of sleeve gastrectomy converted to Roux-en-Y gastric bypass and one-anastomosis gastric bypass. Obes Surg. 2022;32:643–51.PubMedPubMedCentralCrossRef

106.

Hany M, Zidan A, Elmongui E, Torensma B. Revisional Roux-en-Y gastric bypass versus revisional one-anastomosis gastric bypass after failed sleeve gastrectomy: a randomized controlled trial. Obes Surg. 2022;32:3491–503.PubMedPubMedCentralCrossRef

107.

Roach E, Laplante S, Stogryn S, Maeda A, Jackson T, Okrainec A. Weight loss outcomes for patients undergoing conversion to Roux‑en‑Y‑gastric bypass after sleeve gastrectomy. Surgical Endosc https://doi.org/10.1007/s00464-022-09506-1.

108.

Zadeh JR, Alvarez R, Khaitan L, Abbas M. Conversion of gastric sleeve to Roux-en-Y gastric bypass: overall outcomes and predictors of below-average weight loss. Surg Obes Relat Dis. 2023;19(2):111–7. https://doi.org/10.1016/j.soard.2022.10.029.CrossRefPubMed

109.

Nergaards BJ, Leifsson RG, Hedenbro J, Gislason H. Gastric bypass with long alimentary limb or long pancreato-biliary limb- Long-term results on weight loss, resolution of comorbidities and metabolic parameters. Obes Surg. 2014;24:1595–602.CrossRef

110.

Smelt HJM, Van Rijn S, Pouwels S, Aarts MPW, Smulders JF. The influence of different alimentary and biliopancreatic limb lengths in gastric bypass patients. Obes Surg. 2021;31:481–9.PubMedCrossRef

111.

Nora M, Morais T, Almeida R, Guimaraes M, Monteiro M. Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes? Medicine. 2017;96:48.CrossRef

112.

Shah K, Nergaard BJ, Fagerland MW, Gislason H. Distal gastric bypass: 2-m biliopancreatic limb construction with varying lengths of common channel. Surg Obes Relat Dis. 2019;15:1520–6.PubMedCrossRef

113.

Eskandaros MS, Abbass A. Standard biliopancreatic limb (50 cm) Roux-en-Y gastric bypass versus long biliopancreatic limb (100 cm) Roux-en-Y gastric bypass in patients with body mass index 40–50 kg/m²: a randomized prospective study. Obes Surg. 2022;32:577.PubMedCrossRef

114.

Kraljevic M, Süsstrunk J, Köstler T, Lazaridis II, Zingg U, Delko T. Short or long biliopancreatic limb bypass as a secondary procedure after failed laparoscopic sleeve gastrectomy. Obes Surg. 2021;31:170–8.PubMedCrossRef

115.

Yorke E, Sheppard C, Switzer NJ, et al. Revision of sleeve gastrectomy to Roux-en-Y gastric bypass: a Canadian experience. Am J Surg. 2017;213:970–4.PubMedCrossRef

116.

Carmeli I, Golomb I, Sadot E, Kahstan H, Keidar A. Laparoscopic conversion of sleeve gastrectomy to a biliopancreatic diversion with duodenal switch or a Roux-en-Y gastric bypass due to weight loss failure: our algorithm. Surg Obes Relat Dis. 2015;11:79–87.PubMedCrossRef

117.

Freider JS, Aleman R, Ortiz-Gomez C, et al. Outcomes of reoperative surgery in severely obese patients after sleeve gastrectomy: a single-institution experience. Surg Obes Relat Dis. 2020;16:983–90.CrossRef

118.

Spivak H, Giorgi M, Luhrs A. Conversion of gastric sleeve to Roux-en-Y gastric bypass and biliopancreatic diversion/duodenal switch: safe and viable options. Surg Obes Relat Dis 2022https://doi.org/10.1016/j.soard.2022.10.024

119.

Poghosyan T, Alameh A, Bruzzi M, Faul A, Rives-Lange C, Zinzindohoue F, et al. Conversion of sleeve gastrectomy to one anastomosis gastric bypass for weight loss failure. Obes Surg. 2019;29(8):2436–1441.PubMedCrossRef

120.

Kermansaravi M, Karami R, Valizadeh R et al. Five-year outcomes of one anastomosis gastric bypass as conversional surgery following sleeve gastrectomy for weight loss failure. Sci Rep. 2022;12(1):10304. Published 2022 Jun 18. https://doi.org/10.1038/s41598-022-14633-9

121.

Debs T, Petrucciani N, Kassir R, Juglard G, Gugenheim J, Iannelli A, et al. Laparoscopic conversion of sleeve gastrectomy to one anastomosis gastric bypass for weight loss failure: mid-term results. Obes Surg. 2020;30(6):2259–65.PubMedCrossRef

122.

Rheinwalt KP, Schipper S, Plamper A, et al. Roux-en-Y versus one anastomosis gastric bypass as redo-operations following sleeve gastrectomy: a retrospective study. World J Surg. 2022;46(4):855–64. https://doi.org/10.1007/s00268-021-06424-6.CrossRefPubMed

123.

Rayman S, Assaf D, Azran C, et al. Sleeve gastrectomy failure-revision to laparoscopic one-anastomosis gastric bypass or Roux-n-Y gastric bypass: a multicenter study. Obes Surg. 2021;31(7):2927–34. https://doi.org/10.1007/s11695-021-05334-9.CrossRefPubMed

124.

Dantas ACB, Branco LT, Tustumi F, de Oliveira DRCF, Pajecki D, Santo MA. One-anastomosis gastric bypass versus Roux-en-Y gastric bypass as revisional surgery after sleeve gastrectomy: a systematic review and meta-analysis. Obes Surg. 2022;32(12):4082–8. https://doi.org/10.1007/s11695-022-06326-z.CrossRefPubMed

125.

Maurice AP, Miron SW, Yaksich LR, Hopkins GH, Dodd BR. Revisional bariatric surgery to single-anastomosis gastric bypass: a large multi-institutional series. Surg Obes Relat Dis. 2021;17(6):1080–7.PubMedCrossRef

126.

Parmar CD, Gan J, Stier C, et al. One anastomosis/mini gastric bypass (OAGB-MGB) as revisional bariatric surgery after failed primary adjustable gastric band (LAGB) and sleeve gastrectomy (SG): a systematic review of 1075 patients. Int J Surg. 2020;81:32–8. https://doi.org/10.1016/j.ijsu.2020.07.007.CrossRefPubMed

127.

Balibrea JM, Vilallonga R, Hidalgo M, Ciudin A, González O, Caubet E, Sánchez-Pernaute A, Fort JM, Armengol-Carrasco M. Mid-term results and responsiveness predictors after two-step single-anastomosis duodeno-ileal bypass with sleeve gastrectomy. Obes Surg. 2016;27:1302–8.CrossRef

128.

Zaveri H, Surve A, Cottam D, Cottam A, Medlin W, Richards C, Horsley B. Mid-term 4-year outcomes with single anastomosis duodenal-ileal bypass with sleeve gastrectomy surgery at a single US center. Obes Surg. 2018;28:3062–72.PubMedCrossRef

129.

Bashah M, Aleter A, Baazaoui J, El-Menyar A, Torres A, Salama A. Single anastomosis duodeno-ileostomy (SADI-S) versus one anastomosis gastric bypass (OAGB-MGB) as revisional procedures for patients with weight recidivism after sleeve gastrectomy: a comparative analysis of efficacy and outcomes. Obes Surg. 2020;30:4715–23.PubMedPubMedCentralCrossRef

130.

Dijkhorst PJ, Al Nawas M, Heusschen L, Hazebroek EJ, Swank DJ, Wiezer RMJ, Aarts EO. Single anastomosis duodenoileal bypass or Roux-en-Y gastric bypass after failed sleeve gastrectomy: medium-term outcomes. Obes Surg. 2021;31:4708–16.PubMedPubMedCentralCrossRef

131.

Liagre A, Martini F, Anduze Y, Boudrie H, Van Haverbeke O, Valabrega S, Petrucciani N. Efficacy and drawbacks of single-anastomosis duodeno-ileal bypass after sleeve gastrectomy in a tertiary referral bariatric center. Obes Surg. 2021;31:2691–700.PubMedPubMedCentralCrossRef

132.

Andalib A, Bouchard P, Alamri H, Bougie A, Demyttenaere S, Court O. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S): short-term outcomes from a prospective cohort study. Surg Obes Relat Dis. 2021;17:414–24.PubMedCrossRef

133.

Sánchez-Pernaute A, Rubio MÁ, Pérez N, Marcuello C, Torres A, Pérez-Aguirre E. Single-anastomosis duodeno-ileal bypass as a revisional or second-step operation after sleeve gastrectomy. Surg Obes Relat Dis. 2020;16:1491–6.PubMedCrossRef

134.

Osorio J, Lazzara C, Admella V, Franci-León S, Pujol-Gebellí J. Revisional laparoscopic SADI-S vs. duodenal switch following failed primary sleeve gastrectomy: a single-center comparison of 101 consecutive cases. Obes Surg. 2021;31: 3667–3674

135.

Jen J, Phan H, Johnson B, et al. Comparing weight loss outcomes after conversion to Roux-en-Y gastric bypass versus duodenal switch from sleeve gastrectomy in a community hospital. Surg Endosc. 2022;5:1–10.

136.

Kaleb Lourensz K, Himantoko I, Shaw K, Laurie Ch, Becroft L, Forrest E, Nottle P, Fineberg D, Burton P, Brown W. Long-term outcomes of revisional malabsorptive bariatric surgery: do the benefits outweigh the risk? Obes Surg. 2022;32:1822–30.PubMedPubMedCentralCrossRef

137.

Copãescu C. Laparoscopic biliopancreatic diversion with duodenal switch - the most effective operation for type 2 diabetes mellitus. How I do it? Chirurgia. 2018;113:704–711

138.

Sessa L, Guidone C, Gallucci P, Capristo E, Mingrone G, Raffaelli M. Effect of single anastomosis duodenal-ileal bypass with sleeve gastrectomy on glucose tolerance test: comparison with other bariatric procedures. Surg Obes Relat Dis. 2019;15:1091–7.PubMedCrossRef

139.

Pereira SS, Guimarães M, Almeida R, Pereira AM, Lobato CB, Hartmann B, Hilsted L, Holst JJ, Nora M, Mariana PM. Biliopancreatic diversion with duodenal switch (BPD-DS) and single- anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) result in distinct post-prandial hormone profiles. Int J Obes. 2019;43:2518–27.CrossRef

140.

Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(11):4823–43.PubMedCrossRef

141.

Istfan NW, Anderson WA, Hess DT, Yu L, Carmine B, Apovian CM. The mitigating effect of phentermine and topiramate on weight regain after Roux-en-Y gastric bypass surgery. Obesity. 2020;28(6):1023–30.PubMedCrossRef

142.

Stanford FC, Alfaris N, Gomez G, et al. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: a multicenter study. Surg Obes Relat Dis. 2017;13(3):491–500.PubMedCrossRef

143.

Schwartz J, Suzo A, Wehr AM, et al. Pharmacotherapy in conjunction with a diet and exercise program for the treatment of weight recidivism or weight loss plateau post-bariatric surgery: a retrospective review. Obes Surg. 2016;26(2):452–8.PubMedCrossRef

144.

Wharton S, Kuk JL, Luszczynski M, Kamran E, Christensen RAG. Liraglutide 3.0 mg for managing insufficient weight loss or excessive weight regain post‐bariatric surgery. Clin Obes. 2019;9(4).

145.

Miras AD, Pérez-Pevida B, Aldhwayan M, et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(7):549–59.PubMedCrossRef

146.

Thakur U, Bhansali A, Gupta R, Rastogi A. Liraglutide augments weight loss after laparoscopic sleeve gastrectomy: a randomised, double-blind. Placebo-control study Obes Surg. 2021;31(1):84–92.PubMedCrossRef

147.

Mok J, Adeleke MO, Brown A, Magee CG, Firman C, Makahamadze C, Jassil FC, Marvasti P, Carnemolla A, Devalia K, Fakih N, Elkalaawy M, Pucci A, Jenkinson A, Adamo M, Omar RZ, Batterham RL, Makaronidis J. Safety and efficacy of liraglutide, 3.0 mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical trial. JAMA Surg. 2023 Oct 1;158(10):1003–1011.

148.

Lautenbach A, Wernecke M, Huber TB, et al. The potential of semaglutide once-weekly in patients without type 2 diabetes with weight regain or insufficient weight loss after bariatric surgery—a retrospective analysis. Obes Surg. 2022;32(10):3280–8.PubMedPubMedCentralCrossRef

149.

Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002.PubMedCrossRef

150.

Jensen AB, Renström F, Aczél S, et al. Efficacy of the glucagon-like peptide-1 receptor agonists liraglutide and semaglutide for the treatment of weight regain after bariatric surgery: a retrospective OMBServational Study. Obes Surg. Published online February 11, 2023.

151.

Vosburg RW, El Chaar M, El Djouzi S, et al. Literature review on anti-obesity medication use for metabolic and bariatric surgery patients from the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. Surg Obes Relat Dis. 2022;18(9):1109–19.PubMedCrossRef

152.

Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–16.PubMedCrossRef

153.

Jastreboff AM, Kaplan LM, Frías JP, et al. Triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial [published online ahead of print, 2023 Jun 26]. N Engl J Med. 2023

154.

Becerril S, Frühbeck G. Cagrilintide plus semaglutide for obesity management. Lancet. 2021;397(10286):1687–9.PubMedCrossRef

Title: Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement
Authors: Ashraf Haddad
Michel Suter
Jan Willem Greve
Scott Shikora
Gerhard Prager
Barham Abu Dayyeh
Manoel Galvao
Karen Grothe
Miguel Herrera
Lilian Kow
Carel Le Roux
Mary O’Kane
Chetan Parmar
Luiz Gustavo Quadros
Almino Ramos
Josep Vidal
Ricardo V Cohen
Publication date: 14-10-2024
Publisher: Springer US
Keywords: Bariatric Surgery
Bariatric Surgery
Obesity
Obesity
Published in: Obesity Surgery / Issue 11/2024
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-024-07489-7

Reply to Comments on Article: “Laparoscopic Sleeve Gastrectomy as a First Step Procedure for Oncologic Purposes – an Indication Beyond the Updated Guidelines”

Sleeve Gastrectomy
Correspondence

Extended Length of Stay After Bariatric Surgery in China: Advantage or Disadvantage?

Obesity
Editorial

Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

Open Access
Bariatric Surgery
Original Contributions

Impact of Leptin-Melanocortin Pathway Genetic Variants on Weight Loss Outcomes After Endoscopic Transoral Outlet Reduction

Obesity
Original Contributions

Correction to: Gastrogastric Intussusception 10 Years After Laparoscopic Gastric Greater Curvature Plication: a Case Report

Open Access
Correction

Validity of Continuous Glucose Monitoring for the Diagnosis of Dumping Syndrome After Metabolic Surgery, in Comparison to the Oral Glucose Tolerance Test

Original Contributions

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Chronic Pancreatitis
On-demand webinar

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Podcast | Sexual health in older age

Springer Medicine

Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement

Abstract

Other articles of this Issue 11/2024

Reply to Comments on Article: “Laparoscopic Sleeve Gastrectomy as a First Step Procedure for Oncologic Purposes – an Indication Beyond the Updated Guidelines”

Extended Length of Stay After Bariatric Surgery in China: Advantage or Disadvantage?

Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

Impact of Leptin-Melanocortin Pathway Genetic Variants on Weight Loss Outcomes After Endoscopic Transoral Outlet Reduction

Correction to: Gastrogastric Intussusception 10 Years After Laparoscopic Gastric Greater Curvature Plication: a Case Report

Validity of Continuous Glucose Monitoring for the Diagnosis of Dumping Syndrome After Metabolic Surgery, in Comparison to the Oral Glucose Tolerance Test

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Podcast | Sexual health in older age

Springer Medicine

Abstract

Please log in to get access to this content